Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.19.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
Revenues $ 0 $ 50,000
Costs and Expenses    
Operating expenses 1,853,000 2,938,000
Research and development expenses 208,000 243,000
Loss before other income (expense) (2,061,000) (3,131,000)
Interest and financing expense (998,000) (1,704,000)
Net loss $ (3,059,000) $ (4,835,000)
Net loss per common share, basic and diluted $ (0.01) $ (0.02)
Weighted average common shares outstanding, basic and diluted 246,255,784 217,790,405